C WorldWide Group Holding A/S - ACCELERON PHARMA INC ownership

ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 177 filers reported holding ACCELERON PHARMA INC in Q2 2018. The put-call ratio across all filers is 2.13 and the average weighting 0.2%.

Quarter-by-quarter ownership
C WorldWide Group Holding A/S ownership history of ACCELERON PHARMA INC
ValueSharesWeighting
Q4 2018$224,000
-25.8%
5,146
-2.5%
0.00%
-25.0%
Q3 2018$302,000
+37.3%
5,278
+16.3%
0.00%
+33.3%
Q2 2018$220,000
+24.3%
4,5370.0%0.00%0.0%
Q1 2018$177,000
-10.6%
4,537
-2.7%
0.00%0.0%
Q4 2017$198,000
-1.5%
4,662
-13.3%
0.00%0.0%
Q3 2017$201,000
+45.7%
5,376
+18.4%
0.00%
+50.0%
Q2 2017$138,000
+6.2%
4,539
-7.3%
0.00%0.0%
Q1 2017$130,000
-4.4%
4,897
-8.0%
0.00%
-33.3%
Q4 2016$136,000
-77.1%
5,320
-67.6%
0.00%
-70.0%
Q3 2016$594,000
+6.6%
16,4000.0%0.01%
-9.1%
Q2 2016$557,000
+28.6%
16,4000.0%0.01%
+37.5%
Q1 2016$433,000
-45.9%
16,4000.0%0.01%
-42.9%
Q4 2015$800,000
+79.8%
16,400
-8.2%
0.01%
+100.0%
Q3 2015$445,000
-59.8%
17,860
-49.0%
0.01%
-12.5%
Q2 2015$1,108,000
+177.0%
35,000
+233.3%
0.01%
+33.3%
Q1 2015$400,000
-2.2%
10,5000.0%0.01%0.0%
Q4 2014$409,000
+31.1%
10,5000.0%0.01%
+20.0%
Q3 2014$312,00010,5000.01%
Other shareholders
ACCELERON PHARMA INC shareholders Q2 2018
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,449,300$59,537,000,0006.61%
Foresite Capital Management II, LLC 188,602$7,748,0004.36%
Foresite Capital Management III, LLC 254,923$10,472,0003.43%
Artal Group S.A. 1,500,000$61,620,0002.49%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,305,174$53,617,0001.93%
Asymmetry Capital Management, L.P. 82,473$3,388,0001.84%
QVT Financial LP 190,977$7,845,0001.66%
SECTORAL ASSET MANAGEMENT INC 269,396$11,067,0001.32%
Sofinnova Investments, Inc. 241,043$9,902,0000.91%
Novo Holdings A/S 119,708$4,918,0000.69%
View complete list of ACCELERON PHARMA INC shareholders